Clinical Pathways for Effective and Appropriate Care

NCT00673491 | Completed DMC

• 1 other identifier: DCPIEAC-EXART12MARCHE
• Study Type: interventional
• Target: 448
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purposes of this study are to determine whether clinical pathways: 1)improve the quality of the care provided to patients affected by stroke in terms of clinical outcomes, efficiency continuity of care and patients' satisfaction; 2) facilitate the use of evidence based medicine in clinical practice.

Conditions

Stroke

Keywords

Critical Pathways; Stroke; Randomized Controlled Trial; Effectiveness

Outcome Measures

Primary Outcomes (1)

• Mortality

  30 days after hospital admission

Secondary Outcomes (1)

• Disability

  At hospital discharge

Study Arms (2)

1

EXPERIMENTAL

Patients treated according to clinical pathways

Other: Clinical Pathways

2

NO INTERVENTION

Patients treated according to usual care

Interventions

Clinical Pathways OTHER

Clinical pathways are a methodology for the mutual decision making and organization of care for a well-defined group of patients during a well-defined period. Defining characteristics of clinical pathways includes: an explicit statement of the goals and key elements of care based on evidence, best practice, and patient expectations; the facilitation of the communication, coordination of roles, and sequencing the activities of the multidisciplinary care team, patients and their relatives; the documentation, monitoring, and evaluation of variances and outcomes; and the identification of the appropriate resources.

1

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Principal diagnosis of Ischemic Stroke (ICD9CM code 434.91)

You may not qualify if:

• Transient cerebral ischemia (ICD9CM code 435.9)
• Intracerebral hemorrhage (ICD9CM codes 431.xx)

Sponsors & Collaborators

• Agenzia Regionale Sanitaria delle Marche: lead
• Agenzia Nazionale per i Servizi Sanitari Regionali: collaborator
• Regione Friuli Venezia Giulia: collaborator
• Reggio Calabria: collaborator
• Forum della Solidarieta: collaborator
• IRCCS Besta: collaborator
• Regione Molise: collaborator
• Regione Puglia: collaborator
• Regione Siciliana: collaborator
• Regione Umbria: collaborator
• University of Eastern Piedmont: collaborator

Related Publications (2)

• Panella M, Marchisio S, Brambilla R, Vanhaecht K, Di Stanislao F. A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study. BMC Med. 2012 Jul 10;10:71. doi: 10.1186/1741-7015-10-71.

  PMID: 22781160 DERIVED

• Panella M, Marchisio S, Barbieri A, Di Stanislao F. A cluster randomized trial to assess the impact of clinical pathways for patients with stroke: rationale and design of the Clinical Pathways for Effective and Appropriate Care Study [NCT00673491]. BMC Health Serv Res. 2008 Nov 3;8:223. doi: 10.1186/1472-6963-8-223.

  PMID: 18980664 DERIVED

MeSH Terms

Conditions

Stroke

Interventions

Critical Pathways

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Patient Care Planning; Comprehensive Health Care; Patient Care Management; Health Services Administration

Study Officials

• Francesco Di Stanislao, MD

  Agenzia Regionale Sanitaria delle Marche

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV

Study Record Dates

• First Submitted: May 5, 2008
• First Posted: May 7, 2008
• Study Start: July 1, 2005
• Primary Completion: May 1, 2007
• Study Completion: May 1, 2007
• Last Updated: May 7, 2008

Record last verified: 2008-05